secwatch.observer — SEC 8-K summary
======================================

Issuer:     GLOBUS MEDICAL INC (GMED)
CIK:        0001237831
Form:       8-K
Filed at:   2023-05-03T23:59:59+00:00
Accession:  0001193125-23-134571
Event type: regulatory
Sentiment:  neutral
Materiality: 0.60
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Globus Medical, NuVasive get FTC second request for merger; Q3 2023 close expected
--------------------------------------------------------------------------------

- FTC issued Second Request on May 3, 2023, extending HSR waiting period for the merger.
- Both companies received requisite stockholder approvals at April 27, 2023 meetings.
- Merger expected to close in Q3 2023, subject to HSR clearance and other conditions.
- Globus and NuVasive are cooperating with FTC to satisfy the Second Request.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1237831/000119312523134571/0001193125-23-134571-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1237831/000119312523134571/d352462d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-134571

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer